CLOs on the Move

Stimwave Technologies

www.stimwavefreedom.com

 
Stimwave Technologies Inc is a privately-held medical device company engaged in the development, manufacture, commercialization and marketing of wireless microsize injectable medical devices for neurology markets. Stimwave strives to improve people`s lives through utilizing wireless neurostimulation technology that enables low cost alternatives to complicated and expensive surgery, coupled with convenient and safe methods of use easily incorporated into everyday life.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Turner Imaging Systems

Turner Imaging Systems has a long history of miniaturizing technologies for the healthcare space. Our latest innovation is the truly portable mini C-arm, the Smart-C The Turner Imaging Systems Smart-C is a mini C-arm X-ray system designed to provide physicians with realtime general fluoroscopic visualization of adult and pediatric patients. It is intended to aid physicians and surgeons during diagnostic procedures, therapeutic treatment or surgical procedures of the limbs, extremities or shoulders, including, but not limited to, orthopedics and emergency medicine. The Smart-C is intended to be used on a table or other hard, flat surface. It may also be used with the optional support stand.

Medical Supply Corporation

Medical Supply Corporation is a Ferndale, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

INTEGRATED MEDICAL TECHNOLOGIES USA

INTEGRATED MEDICAL TECHNOLOGIES USA, LLC is a Circle Pines, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Freeman Manufacturing Co.

Freeman Manufacturing Co. is a Sturgis, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Tearlab

TearLab Corporation develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease markers in tears at the point-of-care. Headquartered in San Diego, CA, TearLab Corporation`s common shares trade on the NASDAQ Capital Market under the symbol `TEAR` and on the Toronto Stock Exchange under the symbol `TLB`. Dry Eye Disease (DED) is a chronic, progressive disease. Morgan Stanley’s Dry Eye Market Report (2003) estimates that 30 to 60 million Americans suffer from dry eye symptoms. Only 10 million are diagnosed with the disease. Millions more suffer worldwide. The TearLab™ Osmolarity System provides the first quantitative and objective diagnostic technology that allows doctors to effectively manage their dry eye patients. TearLab will allow practitioners to diagnosis DED patients early in the disease process allowing for early intervention. TearLab received the CE Mark for its TearLab Osmolarity System in 2008 and FDA Clearance in 2009. TearLab is currently marketed globally in more than 14 countries including the US.